01—Abstract
Summary
Summary of the 8-K filed June 27, 2019. Cited figures are marked; the original filing is the authoritative source.
Moderna, Inc. filed an 8-K on June 27, 2019, to report the results of its 2019 Annual Meeting of Stockholders.
The primary focus of this filing was the outcomes of shareholder votes on key corporate governance matters. Investors would note the election of directors and the ratification of the company's independent auditor. These votes are generally routine but indicate shareholder confidence in the current leadership and financial oversight.
Of particular interest to investors is the overwhelming support for the election of directors Noubar Afeyan, Stéphane Bancel, and Peter Barton Hutt. The ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019, also received substantial approval. These results suggest continued shareholder alignment with the company's strategic direction and financial reporting integrity.
02—Key points
Key Highlights
- Moderna, Inc. held its 2019 Annual Meeting of Stockholders on June 27, 2019.
- Shareholders elected Noubar Afeyan, Stéphane Bancel, and Peter Barton Hutt as Class I directors for a three-year term.
- All nominated directors received a significant majority of votes in favor of their election.
- Shareholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2019.
- The ratification of the auditor was strongly supported by an overwhelming majority of votes.
- The filing confirms that a quorum was present at the Annual Meeting.
- Moderna, Inc. is identified as an 'emerging growth company' in this filing.
03—Questions
Frequently Asked Questions
What was the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing was to report the final voting results from Moderna, Inc.'s 2019 Annual Meeting of Stockholders, including the election of directors and the ratification of the independent auditor.
Who were the directors elected at the Annual Meeting?
The directors elected for a three-year term were Noubar Afeyan, Ph.D., Stéphane Bancel, and Peter Barton Hutt, LL.M.
Who is Moderna's independent auditor for the fiscal year 2019?
Ernst & Young LLP was ratified by the stockholders as Moderna's independent registered public accounting firm for the year ending December 31, 2019.
Did the shareholders express strong support for the proposed items?
Yes, both the election of directors and the ratification of the independent auditor received substantial majority support from the voting shareholders, indicating confidence in the company's governance and financial oversight.
04—Continue